“FDA Agrees to New Trials for Ecstasy as Relief for PTSD Patients”

0
241

Last week, the FDA gave permission for ecstasy to move into Phase 3 clinical trials for the treatment of PTSD. “If they can keep getting good results, it will be of great use. PTSD can be very hard to treat. Our best therapies right now don’t help 30 to 40 percent of people. So we need more options.”

Article →­

ecstasy-for-ptsd

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time